Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

18 results for Pharmaceuticals
CLEAR ALL
Actylis
Plasticizer and coating excipient for several oral solid dosage formulations. It is used in various drug formulations that are intended for NDA and ANDA filing.Benefits:
  • Shows strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
  • China DMF No. : CDE # F20200000446
Hisun Pharmaceutical
API designed for use in animal pharmaceutical products. Benefits:
  • Complies with US VMF, CA VMF, CEP and WHO DMF specifications
  • USP, EP and CVP certified
Actylis
Excipient developed for pharmaceutical applications. It is used as a solvent in oral solid dosage forms. Benefits:
  • Highly pure
  • Complies with USP-NF and Ph Eur specifications
Actylis
Binder, lubricant, plasticizer, coating agent and ointment base for pharma applications. It is a permeation-enhancing solvent developed for transdermal drug delivery systems. Benefits:
  • Demonstrates superior performance offering enhanced skin permeation thereby improving the drug efficacy
  • Displays strong control on all…
Zhuhai United Laboratories
API developed for pharmaceutical formulations. It is semi-synthetic penicillin to treat upper and lower respiratory tract infections. Benefits:
  • Complies with USP, EP and BP
  • Meets with DMF, US DMF and CEP specifications
API designed for pharmaceutical applications. It is semi-synthetic penicillin. It is used to treat bacterial infections. Benefits:
  • Available in micronized powder
  • Complies with USP, EP and BP
  • Meets with DMF, US DMF and CEP specifications
Zhuhai United Laboratories
API designed for pharmaceutical applications. It is semi-synthetic penicillin. It is used to treat bacterial infections.Benefits:
  • Available in white crystalline powder
  • Complies with USP, EP and BP 
  • Meets with DMF, US DMF and CEP regulations
Zhuhai United Laboratories
API designed for use in pharmaceutical formulations. It is semi-synthetic penicillin. It is used to treat bacterial infections.Benefits:
  • Available in crystalline powder form
  • Complies with USP, BP and EP
  • Meets with DMF, US DMF and CEP specifications
Actylis
Excipients for injectable formulations. It is recommended for pharmaceutical applications like haemodialysis.Benefits:
  • Acts as buffering agents/pH modifiers
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Solvent and co-solvent designed for injectable formulations. This excipient is used as a buffering agent and pH modifier. Benefits:
  • Highly pure, gives sweet taste
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with CDMF, USP, Ph Eur specification
Actylis
Excipient designed for pharmaceutical applications. It is used to adjust pH in solid and semi-solid dosage formulations.Benefits:
  • Complies with USP, Ph Eur and CP specifications
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189